Project Grant R01DA064612
Award Date 3/15/26
Completion Date 12/31/30
Dollars Obligated $634K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Denver, CO 80204, USA
Similar Awards
- Federal Project Grant Award Summary Oregon Health & Science University received a $736,713 Project Grant award from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279), effective February 15, 2026, with a completion date of November 30, 2030. The award funds the Psilocybin Research and Implementation Study for Mental Health and Substance Use (PRISM), designed to evaluate the safety and effectiveness of state-regulated psilocybin...
- Federal Grant Award Summary This $412,500 project grant award, funded by the National Institutes of Health (NIH) Office of the Director under the Trans-NIH Research Support program (CFDA 93.310) and executed through Massachusetts General Hospital, supports a longitudinal research study examining the effects of naturalistic hallucinogen use on internalizing symptoms in young adults. The project, spanning from August 6, 2025, through July 31, 2030, delivers rigorous epidemiological analysis...
- Federal Project Grant Award Summary The Medical University of South Carolina received a $139,851 Project Grant award from the National Institute on Drug Abuse under the Drug Use and Addiction Research Programs (CFDA 93.279) effective October 10, 2025, with a completion date of April 30, 2028. This award supports research investigating the therapeutic potential of psilocybin in treating stress-induced relapse in patients with opioid use disorder (OUD) and comorbid post-traumatic stress disorder...
- Federal Grant Award Summary New York University School of Medicine is conducting a clinical research project funded by the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242). The $871,225 project grant, awarded March 1, 2026, with a completion date of November 30, 2030, investigates psilocybin as a novel therapeutic intervention for residual anhedonia in patients currently taking selective serotonin reuptake inhibitors (SSRIs). The research...
- Federal Project Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded Icahn School of Medicine at Mount Sinai a Project Grant totaling $507,000 under the Drug Use and Addiction Research Programs (CFDA 93.279) to conduct research titled "Multiscale Insights into the Epigenetic Basis of THC Consumption." The award, effective September 1, 2025, through May 31, 2030, supports translational research investigating the neurobiological mechanisms underlying cannabis use...
- Federal Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded The Feinstein Institutes For Medical Research a $616,372 Project Grant under the Drug Use and Addiction Research Programs (CFDA 93.279) beginning July 15, 2025, with a completion date of March 31, 2030. This award supports research investigating transposable element (TE) expression and regulation in the context of HIV-1 infection and cannabinoid exposure at the single-cell and nuclei level. The research leverages a...
- Federal Project Grant Award Summary Dartmouth College received a $450,313 Project Grant from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) effective June 1, 2025, through May 31, 2027. The award funds research investigating the impact of psychotherapeutic advertising claims (PAC) and mental health warning labels on cannabis purchasing behaviors among light-to-moderate cannabis users experiencing depression and/or anxiety symptoms....
- Federal Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded The Johns Hopkins University a $465,250 Project Grant effective September 1, 2025 through August 31, 2027 under the Drug Use and Addiction Research Programs (CFDA 93.279). This award supports a human laboratory research study investigating pregnenolone as a potential pharmacological treatment for cannabis intoxication. The research will conduct a within-subjects, double-blind, placebo-controlled clinical trial with...
- Federal Grant Award Summary The National Institute on Drug Abuse awarded a $3.24 million Project Grant (CFDA 93.279: Drug Use and Addiction Research Programs) to Kaiser Foundation Hospitals, effective June 1, 2025, through February 28, 2030. This research initiative comprehensively characterizes substance use disorder (SUD) care pathways and compares their quality and effectiveness using data from Kaiser Permanente Washington, a large integrated healthcare system. The study leverages...
- Federal Project Grant Award Summary Princeton University received a $246,000 Project Grant from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) awarded June 15, 2025, with completion targeted for May 31, 2027. The grant supports fundamental neuroscience research investigating the systems-level brain mechanisms underlying psilocybin's therapeutic potential for treating anxiety, depression, addiction, pain, and illness-associated...